Back to the main directory
EarningsReview / Equity
- 4Q24 results: Outlook & buyback helpful but Vaccines to decline by BNP Paribas Exane
- FY24 results first take by BNP Paribas Exane
- Q424 results: Slightly underwhelming CCF print by BNP Paribas Exane
- 4Q24 first take: Mixed: Q4 EBIT 24% beat (from forest reval); H1 guide bounds cons.; surprise buyback; Leuna delayed again by BNP Paribas Exane
- Italian Wine Brands S.p.A. - A profitable strategy! by MidCap Partners
- TOTALENERGIES: RDOS. 4T’24 (ANÁLISIS BANCO SABADELL) by Sabadell
- Non material data changes by BNP Paribas Exane
- Reaffirmed growth guidance for FY25 by BNP Paribas Exane
- STEEL US, CBAM, US SCRAP, US PLATE, NUE, PREVIEW, MT by BNP Paribas Exane
- 东方雨虹（002271 CH） by HSBC
- Confidence on growth improving; expect a strong FY26 by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Q424 conf call: Limited reassurance for CCF by BNP Paribas Exane
- KakaoBank (323410 KS) by HSBC
- An introduction to RS Group by BNP Paribas Exane
- Nielsen suggests underlying market growth 3%, confirms TSCO, SBRY, M&S momentum continues by BNP Paribas Exane
- Q4 conf. call feedback: No clear signs of a residential recovery yet by BNP Paribas Exane
- 2025 Investor Day recap - Building a flywheel by BNP Paribas Exane
- FQ1’25 EPS beat; 2025 guidance maintained by BNP Paribas Exane
- Q4 FT: Financial Solutions soft, but Clover growth re-acceleration, stronger margins, FCF, and 2025 outlook should please the market by BNP Paribas Exane
- GenAI monetisation on track despite Cloud capacity constraints by BNP Paribas Exane
- Itaú BBA on Santander Brasil: 4Q24 Business Good and Slight Beat Via Revenues by Itau
- Enphase Energy Inc (ENPH US) by HSBC
- Well positioned for the Supercycle by BNP Paribas Exane
- Kesko - Increasingly likely that 2024 was the trough year by Danske Bank Equity Research